Latest Market Entry News

Page 29 of 50
ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.
Ada Torres
Ada Torres
22 Sept 2025
BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.
Ada Torres
Ada Torres
18 Sept 2025
Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.
Ada Torres
Ada Torres
18 Sept 2025
Althea Group Holdings has secured $2.55 million through a share placement to fuel expansion of its Canadian THC beverage manufacturing arm, Peak Processing, as it targets growth in both Canadian and US markets.
Victor Sage
Victor Sage
17 Sept 2025
Bioxyne Limited has secured import permits and purchase orders worth A$5.1 million for medical cannabis in Germany, signaling strong early traction in a key European market.
Ada Torres
Ada Torres
15 Sept 2025
Bass Oil Limited reported a 55% increase in EBITDA for the first half of 2025 despite lower oil prices, while progressing key gas field developments to enter the Australian East Coast Gas Market.
Maxwell Dee
Maxwell Dee
9 Sept 2025
Talga Group has signed a strategic cooperation agreement with United Catalyst Corporation, marking its entry into the US battery anode market and setting the stage for new graphite recycling and anode production facilities in South Carolina.
Maxwell Dee
Maxwell Dee
9 Sept 2025
Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.
Ada Torres
Ada Torres
8 Sept 2025
Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.
Ada Torres
Ada Torres
5 Sept 2025
Locksley Resources has listed on the Frankfurt Stock Exchange, boosting its profile in Europe while advancing its Mojave critical minerals project in the U.S. The company is also exploring multiple pathways to enter U.S. capital markets and has secured key government registrations.
Maxwell Dee
Maxwell Dee
4 Sept 2025
Pure Hydrogen Corporation has signed a Letter of Intent with California's GTS Group to supply hydrogen-powered heavy vehicles, marking a strategic push into the North American market.
Victor Sage
Victor Sage
2 Sept 2025
Halo Technologies Holdings Ltd has announced a renounceable pro rata rights issue aiming to raise up to $11 million at $0.024 per share, partially underwritten by Lodge Corporate Pty Ltd. The capital raise will support the company’s UK market entry, local growth, and ongoing software development.
Sophie Babbage
Sophie Babbage
1 Sept 2025